LISA DAVIS: Open Payments
NPI 1629207808 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,285 in 63 payments from 17 companies in 2025. Trend: 2023 $17,419 · 2024 $19,531 · 2025 $15,285
Speaker / faculty: $11,875Food & beverage: $2,059Travel & lodging: $1,351
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 32 | $14,167 |
| Lilly USA, LLC | 7 | $221 |
| Kestra Medical Technology Services, Inc. | 1 | $197 |
| Cleerly, Inc. | 2 | $196 |
| JAZZ PHARMACEUTICALS INC. | 3 | $82 |
| Boston Scientific Corporation | 2 | $53 |
| HARMONY BIOSCIENCES LLC | 1 | $49 |
| ABIOMED | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $40 |
Products named: REPATHA, Assure WCD, Cleerly Ischemia, MOUNJARO, XYWAV, WATCHMAN FLX, WAKIX, LEQVIO.
Industry payments across FL — which companies pay providers there.
